FARALLON CAPITAL MANAGEMENT LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$14.1B
Holdings
118
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (118 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | INBXUSDINHIBRX INC | 395,000 | $7.1B | 50.41% | |
| 102 | BDQMALBIREO PHARMA INC | 200,000 | $6.7B | 47.32% | |
| 103 | NVLSEURALPINE IMMUNE SCIENCES INC | 741,290 | $6.5B | 46.20% | |
| 104 | IVAINVENTIVA SA | 527,870 | $6.2B | 44.16% | |
| 105 | —RADIUS HEALTH INC | 6,783,000 | $5.5B | 38.81% | |
| 106 | YB4PSAVARA INC | 4,452,086 | $4.9B | 34.41% | |
| 107 | —ARYA SCIENCES ACQUISTION CO | 402,523 | $4.4B | 31.39% | |
| 108 | OPHTEURIVERIC BIO INC | 754,740 | $4.3B | 30.18% | |
| 109 | EQEQUILLIUM INC | 700,000 | $4.0B | 28.64% | |
| 110 | DYNDYNE THERAPEUTICS INC | 200,000 | $4.0B | 28.63% | |
| 111 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 3,522,000 | $3.8B | 27.15% | |
| 112 | —QUOTIENT LTD | 625,000 | $3.2B | 22.78% | |
| 113 | CRDFCARDIFF ONCOLOGY INC | 200,000 | $2.8B | 20.12% | |
| 114 | —FUSION PHARMACEUTICALS INC | 187,600 | $2.3B | 15.99% | |
| 115 | —BROADMARK RLTY CAP INC | 7,174,613 | $2.1B | 14.63% | |
| 116 | AMWLAMERICAN WELL CORP | 45,000 | $1.3B | 9.46% | |
| 117 | —PANDION THERAPEUTICS INC | 100,000 | $1.1B | 8.12% | |
| 118 | GOLGBPGOL LINHAS AEREAS INTELIGENT | 85,838 | $524.0M | 3.72% |
PreviousPage 2 of 2